Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

China flag China · Delayed Price · Currency is CNY
42.97
-0.95 (-2.16%)
Jun 6, 2025, 2:45 PM CST
40.47%
Market Cap 47.69B
Revenue (ttm) 3.86B
Net Income (ttm) 350.11M
Shares Out 1.11B
EPS (ttm) 0.31
PE Ratio 139.22
Forward PE 84.85
Dividend 0.42 (0.94%)
Ex-Dividend Date May 15, 2025
Volume 3,432,948
Average Volume 3,859,449
Open 45.52
Previous Close 43.92
Day's Range 42.62 - 45.52
52-Week Range 25.48 - 47.50
Beta -0.09
RSI 51.18
Earnings Date Aug 15, 2025

About SHE:002653

Haisco Pharmaceutical Group Co., Ltd. research, develops, manufactures, and sells pharmaceuticals products in China. The company offers anesthetic analgesic, neuropsychiatric system, digestive liver disease, and parenteral nutrition medications; drugs for endocrine system and cardiovascular system; oncology-related drugs; andrology drugs; desonide and liprocaine cream; propofol medium/long chain fat emulsion and hydroxyethyl starch sodium chloride injection; sodium fusidicate ointment; lupatadine fumarate tablets; and caspofungin acetate and me... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 5,337
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002653
Full Company Profile

Financial Performance

In 2024, SHE:002653's revenue was 3.72 billion, an increase of 10.92% compared to the previous year's 3.36 billion. Earnings were 395.46 million, an increase of 34.00%.

Financial Statements

News

There is no news available yet.